The Schizophrenia Research Program (SRP) is a division within the Department of Psychiatry dedicated to generating new knowledge in the neurobiology and psychopharmacology of schizophrenia and related psychoses. Its mission is to conduct clinical and translational research to advance the understanding of the causes and treatments of schizophrenia.
SRP research activities include federally funded research projects as well as industry-sponsored clinical trials and investigator-initiated studies.
The major research areas of interest include: brain structure and function, neurochemistry, postmortem histopathology, apoptosis and neurotoxicity, non-dopaminergic antipsychotic agents and metabolic complications.
The SRP collaborates with basic and clinical researchers locally and at other institutions on projects of mutual interest. It also recruits medical students and residents to participate in research and to develop research interest in schizophrenia.